Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains? [Yahoo! Finance]
Insmed Incorporated (INSM)
Last insmed incorporated earnings: 4/30 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insmed.com
Company Research
Source: Yahoo! Finance
The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 16.9% loss over the past four weeks. The stock price rally can be attributed to positive investor mindset regarding the potential of Inovio's novel pipeline of DNA medicine candidates being developed for HPV-related diseases, immune-oncology and infectious diseases, across various stages of clinical development. The company's lead candidate is INO-3107, which is currently undergoing late-stage development for treating recurrent respiratory papillomatosis. This drugmaker is expected to post quarterly loss of $1.20 per share in its upcoming report, which represents a year-over-year change of -11.1%. Revenues are expected to be $0.1 million, down 74.4% from the year-ago quarter. While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earning
Show less
Read more
Impact Snapshot
Event Time:
INSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSM alerts
High impacting Insmed Incorporated news events
Weekly update
A roundup of the hottest topics
INSM
News
- Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $74.00 to $83.00. They now have an "overweight" rating on the stock.MarketBeat
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire
- Insmed To Present at November 2024 Investor ConferencesPR Newswire
- Insmed Incorporated (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $105.00 price target on the stock, up previously from $100.00.MarketBeat
- Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates [Yahoo! Finance]Yahoo! Finance
INSM
Earnings
- 10/31/24 - Miss
INSM
Sec Filings
- 11/19/24 - Form 8-K
- 11/14/24 - Form SC
- 10/31/24 - Form 10-Q
- INSM's page on the SEC website